Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Ovarian Epithelial Cancer Recurrent × Trabectedin × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Sarcoma 18 Ovarian Neoplasms 11 Liposarcoma 7 Leiomyosarcoma 7 Neoplasms 6 Sarcoma, Ewing 3 Neoplasm Metastasis 3 Solitary Fibrous Tumors 2 Sarcoma, Synovial 2 Rhabdomyosarcoma 2 Prostatic Neoplasms 2 Liposarcoma, Myxoid 2 Histiocytoma, Malignant Fibrous 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2 Breast Neoplasms 2 Wilms Tumor 1 Uterine Neoplasms 1 Unspecified Childhood Solid Tumor, Protocol Specific 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Soft Tissue Neoplasms 1 Sarcoma, Endometrial Stromal 1 Sarcoma, Alveolar Soft Part 1 Recurrent High Grade Meningioma 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Epithelial Cancer Recurrent 1 Ovarian Diseases 1 Osteosarcoma 1 Neurofibrosarcoma 1

Interventions

liposomal doxorubicin 1 Trabectedin 1 Docetaxel 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02394015 2020-03-27

RETRO-ROC

Grupo Español de Investigación en Cáncer de Ovario

Ovarian Epithelial Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡